Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pfizer Inc
PFE
Alternate Symbol(s):
N.PFE
Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the...
Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSE:PFE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(4)
•••
johnfever21
X
View Profile
View Bullboard History
Post by
johnfever21
on Mar 30, 2022 8:04am
BioVaxys Expands Cancer Vaccine Platform
BVX-0922 to Target Colorectal Cancer Under Investigator-Sponsored IND VANCOUVER, BC, March 30, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV), (FRA: 5LB), (OTCQB: BVAXF)
...more
(2)
•••
randtr
X
View Profile
View Bullboard History
Post by
randtr
on Mar 17, 2022 9:09am
BioVaxys Announces Bioproduction of BVX-1021 for its
VANCOUVER, BC, March 17, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that it has
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(223)
•••
Heywood_Silvers
X
View Profile
View Bullboard History
Post by
Heywood_Silvers
on Mar 10, 2022 11:21pm
When you dance with the devil......
https://www.sec.gov/Archives/edgar/data/78003/000087666122000258/xslF25X02/primary_doc.xml
(763)
•••
1hot-techwoman
X
View Profile
View Bullboard History
Post by
1hot-techwoman
on Mar 10, 2022 3:42pm
Pfizer to delist !! I wonder why??...LOL
Pfizer to submit delisting application? Pfizer China responded: at present, we have not received any relevant information Mar 09, 2022 06:48 PM (GMT+8)· EqualOcean
...more
(0)
•••
TaylorSwifft
X
View Profile
View Bullboard History
Post by
TaylorSwifft
on Feb 19, 2022 12:49am
FSD Pharma; Recapping 2021 and What to Look Forward in 2022
(76)
•••
lucaM1
X
View Profile
View Bullboard History
Post by
lucaM1
on Feb 09, 2022 12:08pm
Loosing hope
Last year, I was expecting PFE to be up at least 100% by now with their vaccines. Its has shot up 48%, which is great, but I was expecting so much more. This past month has been real bad. When will a
...more
(0)
•••
TaylorSwifft
X
View Profile
View Bullboard History
Post by
TaylorSwifft
on Feb 05, 2022 2:14am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid
...more
(173)
•••
rich39
X
View Profile
View Bullboard History
Post by
rich39
on Feb 01, 2022 3:46pm
Horrible company...
Makes good profit... makes a lot of harm to humans with their products... some day soon its going to all come out...watch out
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Feb 01, 2022 8:32am
Anyone know if Pfizer has diagnostic tool
diagnostic for evaluating T-cell immune response to SARS-CoV-2?
(76)
•••
lucaM1
X
View Profile
View Bullboard History
Post by
lucaM1
on Jan 31, 2022 7:19pm
Price predictions by the end of 2022 for PFE
Comment bellow
(76)
•••
lucaM1
X
View Profile
View Bullboard History
Post by
lucaM1
on Jan 30, 2022 7:25pm
PFE to the moooooon
the brightness here is real ;D
(76)
•••
lucaM1
X
View Profile
View Bullboard History
Post by
lucaM1
on Jan 26, 2022 3:46pm
Pfizer, Moderna, BioNTech, all these stocks are here to stay
Deals with governments, vaccines for the world, these stocks aren't going anywhere.
(32)
•••
Rotaluceps
X
View Profile
View Bullboard History
Comment by
Rotaluceps
on Jan 11, 2022 10:59pm
RE:RE:RE:RE:RE:RE:Natural Immunity versus vaccines - and political criminals
This is iron to fortify the cereal. I was sceptic many years ago when I heard about this but it is a known thing that is so old.
(288)
•••
rad10
X
View Profile
View Bullboard History
Comment by
rad10
on Jan 01, 2022 6:13pm
RE:FSD Pharma Announces Share Repurchase Program
How does a company with zero profitability do this. Minus 20 million earnings last year? Unicorns and tooth fairies....... stick with Pfizer, take profits on Zoetis and double down on
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden